Medical Devices: Page 66
-
Courtesy of Alcon
Alcon to pay J&J $199M to settle dispute over patents for laser eye surgery device
Alcon is settling the case for far less than the $3.1 billion that J&J’s damages expert argued the company could be owed.
By Nick Paul Taylor • Feb. 14, 2023 -
Baxter, Abbott, Thermo Fisher among medtech firms cutting jobs on supply issues, slide in testing
"What COVID gave to diagnostics companies, COVID taketh away now that the virus is endemic,” said one analyst.
By Susan Kelly • Updated Feb. 13, 2023 -
Explore the Trendline➔
Sara Silbiger via Getty Images
TrendlineTop 5 stories from MedTech Dive
From haphazard layoffs at the Food and Drug Administration to the industry’s current IPO environment and tracking FDA-authorized AI devices, here is a collection of top stories from MedTech Dive.
By MedTech Dive staff -
Courtesy of Dexcom
Dexcom secures Medicare coverage for G7 CGM with device set to launch this week
The decision by the CMS will include coverage for people with Type 1 and Type 2 diabetes who are on intensive insulin therapy.
By Elise Reuter • Feb. 13, 2023 -
Retrieved from Medtronic on September 19, 2022
Medtronic ordered by jury to pay $106.5M to Colibri over TAVR patent infringement
Medtronic says the ruling will have no effect on its TAVR business as the patents expired last year and it vowed to appeal the verdict.
By Nick Paul Taylor • Updated Feb. 14, 2023 -
Alex Wong via Getty Images
OpinionPatent trolls’ destructive lawsuits are curbing US medtech innovation
The Patent and Trademark Office must help stop frivolous litigation that is harming the industry, argues former HHS secretary Tom Price.
By Tom Price • Feb. 10, 2023 -
Thermo Fisher cuts additional 230 jobs in California
The job reductions come amid a downturn in demand for COVID-19 tests.
By Susan Kelly • Updated Feb. 10, 2023 -
Courtesy of Philips
82 more deaths linked to Philips’ recalled devices reported to FDA, bringing total to 346
The rate of death reports per month has risen consistently since Philips began the recall in the summer of 2021.
By Nick Paul Taylor • Feb. 10, 2023 -
Tim Boyle via Getty Images
Baxter to cut about 3,000 jobs after earnings slump on supply chain woes
The economic slowdown also hurt profit in the period even as the company posted double-digit sales growth.
By Nick Paul Taylor • Feb. 10, 2023 -
Courtesy of Cardiovascular Systems Inc.
Abbott to pay $890M to acquire CSI, gaining atherectomy device
The deal expands Abbott’s vascular device lineup and access to additional products in development.
By Susan Kelly • Feb. 9, 2023 -
pcess609 via Getty Images
Abbott balloon device partner Surmodics cuts jobs after FDA approval delay
The workforce reduction, one of a growing number in the medtech sector, comes after the agency requested more data in a premarket review of the company’s device to treat narrowed leg arteries.
By Susan Kelly • Feb. 9, 2023 -
Zhanna Hapanovich via Getty Images
Medtech CDMO sector poised for M&A rebound in 2023 amid ‘attractive’ targets: report
Manufacturers that serve other industries are expected to move into medtech through mergers and acquisitions, driving up deal volumes.
By Nick Paul Taylor • Feb. 9, 2023 -
Courtesy of Johnson & Johnson
J&J, Medtronic, Boston Scientific gird for battle over US cardiac ablation market with new trials
Medtech firms are sharing clinical trial results on pulse ablation devices, which they claim are safer and more effective at halting arrhythmias than current methods.
By Elise Reuter • Feb. 8, 2023 -
Pijitra Phomkham via Getty Images
Trade group pushes back on FDA’s clinical decision support guidance
The Clinical Decision Support Coalition is asking the agency to rescind its guidance and propose new rules that change how software tools are regulated as medical devices.
By Elise Reuter • Feb. 8, 2023 -
nay via Getty Images
Onshoring, easing labor market expected to drive double-digit growth at US medtech CDMOs
The report identifies revised rules on ethylene oxide as a trend to watch, noting that new requirements for sterilization could “[clear] the way for structural changes in the industry.”
By Nick Paul Taylor • Feb. 8, 2023 -
Christopher Furlong via Getty Images
UK health system, under strain, lays out medtech strategy
The state-run National Health Service, now facing a strike by nurses and paramedics, hopes new technologies will help solve some of its long-term challenges to improve patient care.
By Susan Kelly • Feb. 7, 2023 -
Permission granted by Abbott Laboratories
Abbott device approval sets up battle with Medtronic, Nevro for diabetic peripheral neuropathy treatment
Three firms are bringing their devices to a $3 billion to $5 billion market, aiming to relieve a painful side effect of diabetes.
By Elise Reuter • Feb. 6, 2023 -
JaysonPhotography via Getty Images
Medtech earnings highlights: Easing of macro pressures, accelerated growth in 2023
Still, the latest round of quarterly results show that hospital staffing and supply chain remain a challenge.
By Nick Paul Taylor • Feb. 6, 2023 -
Ian Waldie via Getty Images
Sensor-loaded, $1 smart glove being tested to reduce stillbirths, maternal deaths
The researchers plan to run clinical trials to show if the device can provide an early warning system for physical impediments to birth.
By Nick Paul Taylor • Feb. 6, 2023 -
Permission granted by Zimmer Biomet
Zimmer Biomet Q4 net loss widens on supply problems; CEO targets acquisitions
The company plans to enter higher-growth markets, even outside of orthopedics, in a bid to increase revenue.
By Elise Reuter • Feb. 3, 2023 -
Courtesy of Invacare
Invacare files for Chapter 11 bankruptcy protection amid supply chain woes
The wheelchair maker said it has reached a restructuring agreement with most of its debt holders and that demand for its products remains strong.
By Susan Kelly • Updated Feb. 3, 2023 -
Permission granted by Becton Dickinson
BD raises full-year forecast, sees Q1 strength in pharmacy automation, pre-fillables
The company’s base businesses helped cushion the impact of declining COVID-19 testing demand.
By Susan Kelly • Feb. 2, 2023 -
Retrieved from Siemsens Website on July 01, 2022
Siemens Healthineers forecasts revenue growth to accelerate despite supply chain woes
Lower diagnostics revenue hurt sales in the three months ended Dec. 31.
By Nick Paul Taylor • Feb. 2, 2023 -
iStock via Getty Images
Vortex ultrasound accelerates brain blood clot clearance in early stage tests
When the ultrasound was formed into a vortex, it cleared more blood clots more quickly than other methods, opening a potential pathway for treatment of cerebral venous sinus thrombosis.
By Nick Paul Taylor • Feb. 2, 2023 -
Boston Scientific gets Q4 boost from heart, urology sales
Following a series of significant acquisitions, the company said it expects net sales growth of about 5% to 7% in full-year 2023.
By Susan Kelly • Feb. 1, 2023 -
CFO survey hints at funding shift from robots to wearables
The poll from accounting firm BDO found the cost and regulatory hurdles of developing robotics devices are often too high, and lower-cost, less-regulated wearables offer better returns.
By Susan Kelly • Feb. 1, 2023
Previous
